Needham analyst Joseph Stringer maintained a Hold rating on Moderna (MRNA – Research Report) today. The company's shares closed last Thursday at $210.17. According to TipRanks.com, Stringer is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of -21.1% and a 20.6% success rate. Stringer covers the Healthcare sector, focusing on stocks such as Phathom Pharmaceuticals, Lexicon Pharmaceuticals, and Apellis Pharmaceuticals. Currently, the analyst consensus on Moderna is a Hold with an average price target of $317.69. See today’s best-performing stocks on TipRanks >> Based on Moderna's latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $4.
https://www.tipranks.com/news/blurbs/needham-maintains-their-hold-rating-on-moderna-mrna?utm_source=advfn.com&utm_medium=referral
Moderna (NASDAQ:MRNA)
Gráfico Histórico do Ativo
De Abr 2022 até Mai 2022 Click aqui para mais gráficos Moderna.
Moderna (NASDAQ:MRNA)
Gráfico Histórico do Ativo
De Mai 2021 até Mai 2022 Click aqui para mais gráficos Moderna.